[144] DocuSign, Inc. SEC Filing
Form 144 for DOCU reports a proposed sale of 983 common shares through Morgan Stanley Smith Barney with an aggregate market value of $78,040.37, slated for approximately 09/11/2025 on NASDAQ. The shares were acquired as performance shares from the issuer on 09/10/2024. The filing also discloses a prior sale by an insider, Robert Chatwani, of 22,875 shares on 06/18/2025 for $1,710,777.77. The notice includes the standard certification that the seller is not aware of undisclosed material adverse information at the time of signing.
- Full Rule 144 details provided: sale quantity, broker, market value, expected sale date, and acquisition details are all disclosed
- Source of shares disclosed: shares were acquired as performance shares from the issuer on 09/10/2024, clarifying the holding origin
- Prior insider sale disclosed: the filing reports a recent sale by Robert Chatwani, increasing transparency about insider activity
- Insider selling activity: Robert Chatwani sold 22,875 shares on 06/18/2025 for $1,710,777.77, which investors may view negatively depending on context
Insights
TL;DR: Scheduled sale of 983 performance shares and a recent insider sale of 22,875 shares; disclosure follows Rule 144 protocol.
The filing documents a routine Rule 144 notice for the planned disposition of 983 common shares with a stated market value of $78,040.37 and an expected sale date of 09/11/2025 via Morgan Stanley Smith Barney. The underlying shares were granted as performance shares on 09/10/2024. Separately, the filing records a recent insider sale by Robert Chatwani of 22,875 shares generating $1,710,777.77 on 06/18/2025. These items are standard insider transaction disclosures and do not, by themselves, indicate undisclosed corporate developments.
TL;DR: Disclosure is complete for a Rule 144 notice; seller attests no material nonpublic information exists.
The Form 144 contains the required information about the securities to be sold, acquisition date and nature (performance shares), broker details, and recent related sales. The signatory’s representation that no material nonpublic information is known is the customary attestation accompanying such notices, helping satisfy compliance expectations for planned insider sales under Rule 144 and 10b5-1 contexts.